Found: 17
Select item for more details and to access through your institution.
Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
In-depth Characterization of Vaccine Breakthrough Infections With SARS-CoV-2 Among Health Care Workers in a Dutch Academic Medical Center.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 1, p. 1, doi. 10.1093/ofid/ofab553
- By:
- Publication type:
- Article
Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15993-y
- By:
- Publication type:
- Article
Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms.
- Published in:
- Journal of the International AIDS Society, 2018, v. 21, n. 9, p. 1, doi. 10.1002/jia2.25185
- By:
- Publication type:
- Article
Lamivudine-Resistant Human Immunodeficiency Virus Type 1 Variants (184V) Require Multiple Amino Acid Changes to Become Co-Resistant to Zidovudine In Vivo.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. 2, p. 398
- By:
- Publication type:
- Article
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC).
- Published in:
- Journal of Infectious Diseases, 1995, v. 171, n. 6, p. 1411, doi. 10.1093/infdis/171.6.1411
- By:
- Publication type:
- Article
A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
- Published in:
- Scientific Reports, 2017, p. 41968, doi. 10.1038/srep41968
- By:
- Publication type:
- Article
Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046622
- By:
- Publication type:
- Article
Failure of Treatment with First-Line Lopinavir Boosted with Ritonavir Can Be Explained by Novel Resistance Pathways with Protease Mutation 76V.
- Published in:
- Journal of Infectious Diseases, 2009, v. 200, n. 5, p. 698, doi. 10.1086/605329
- By:
- Publication type:
- Article
Persistence of HIV-1 Variants with Multiple Protease Inhibitor (PI)--Resistance Mutations in the Absence of PI Therapy Can Be Explained by Compensatory Fixation.
- Published in:
- Journal of Infectious Diseases, 2007, v. 195, n. 3, p. 399, doi. 10.1086/510533
- By:
- Publication type:
- Article
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 182, doi. 10.3390/v16020182
- By:
- Publication type:
- Article
Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 9, p. 2069, doi. 10.3390/v14092069
- By:
- Publication type:
- Article
Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 4, p. 684, doi. 10.1093/cid/ciy565
- By:
- Publication type:
- Article
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-71699-z
- By:
- Publication type:
- Article
A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism.
- Published in:
- PLoS Medicine, 2007, v. 4, n. 1, p. 152, doi. 10.1371/journal.pmed.0040036
- By:
- Publication type:
- Article
Does social need fulfillment moderate the association between socioeconomic status and health risk behaviours during pregnancy?
- Published in:
- European Journal of Public Health, 2024, v. 34, n. 5, p. 929, doi. 10.1093/eurpub/ckae102
- By:
- Publication type:
- Article
Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.
- Published in:
- Retrovirology, 2014, v. 11, n. 1, p. 105, doi. 10.1186/s12977-014-0105-9
- By:
- Publication type:
- Article